Inivata's John Beeler On The Future Of Liquid Biopsies
Executive Summary
John Beeler, vice-president of corporate and business development at Inivata, speaks to Scrip's Lucie Ellis about how the company's technology is aligned with the current genomic medicine revolution facing the pharmaceutical industry.